These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38131131)
1. Application frequency - key indicator for the efficiency of severe dry eye disease treatment - evidence for the importance of molecular weight of hyaluronan in lubricating agents. Medic N; Boldin I; Berisha B; Matijak-Kronschachner B; Aminfar H; Schwantzer G; Müller-Lierheim WGK; van Setten GB; Horwath-Winter J Acta Ophthalmol; 2024 Aug; 102(5):e663-e671. PubMed ID: 38131131 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of 0.15% hylan A eye drops in ameliorating symptoms of severe dry eye patients in Saudi Arabia. Alsheikh O; Alzaaidi S; Vargas JM; Al-Sharif E; Alrajeh M; AlSemari MA; Alhommadi A; Alsaati A; Aljwaiser N; Alshahwan E; Abdulhafiz M; Elsayed R; Müller-Lierheim WGK Saudi J Ophthalmol; 2021; 35(4):293-298. PubMed ID: 35814996 [TBL] [Abstract][Full Text] [Related]
3. A comparison between hyaluronic acid and other single ingredient eye drops for dry eye, a review. Hynnekleiv L; Magno M; Moschowits E; Tønseth KA; Vehof J; Utheim TP Acta Ophthalmol; 2024 Feb; 102(1):25-37. PubMed ID: 37042308 [TBL] [Abstract][Full Text] [Related]
4. Effect of a hyaluronic acid and carboxymethylcellulose ophthalmic solution on ocular comfort and tear-film instability after cataract surgery. Mencucci R; Boccalini C; Caputo R; Favuzza E J Cataract Refract Surg; 2015 Aug; 41(8):1699-704. PubMed ID: 26432128 [TBL] [Abstract][Full Text] [Related]
5. Effect of different lubricant eye gels on tear film thickness as measured with ultrahigh-resolution optical coherence tomography. Wozniak PA; Schmidl D; Bata AM; Fondi K; Witkowska KJ; Aranha Dos Santos V; Baar C; Room KI; Nepp J; Baumgartner I; Popa-Cherecheanu A; Garhöfer G; Werkmeister RM; Schmetterer L Acta Ophthalmol; 2017 Jun; 95(4):e307-e313. PubMed ID: 27989018 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of artificial tears containing trehalose and hyaluronic acid for dry eye disease in women aged 42-54 versus ≥ 55 years. Mateo-Orobia AJ; Del Prado Sanz E; Blasco-Martínez A; Pablo-Júlvez LE; Farrant S; Chiambaretta F Cont Lens Anterior Eye; 2023 Aug; 46(4):101845. PubMed ID: 37117131 [TBL] [Abstract][Full Text] [Related]
7. Impact of Diquafosol Ophthalmic Solution on Tear Film and Dry Eye Symptom in Type 2 Diabetic Dry Eye: A Pilot Study. Zhang Q; Zhang H; Qin G; Wu Y; Song Y; Yang L; Yu S; He X; Moore JE; Moutari S; Palme C; Xu L; He W; Pazo EE J Ocul Pharmacol Ther; 2022 Mar; 38(2):133-140. PubMed ID: 35049373 [No Abstract] [Full Text] [Related]
8. Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study. Sacchetti M; Lambiase A; Schmidl D; Schmetterer L; Ferrari M; Mantelli F; Allegretti M; Garhoefer G Br J Ophthalmol; 2020 Jan; 104(1):127-135. PubMed ID: 30944103 [TBL] [Abstract][Full Text] [Related]
9. Disease aetiology-based design of multifunctional microemulsion eye drops for moderate or severe dry eye: a randomized, quadruple-masked and active-controlled clinical trial. Laihia J; Järvinen R; Wylęgała E; Kaarniranta K Acta Ophthalmol; 2020 May; 98(3):244-254. PubMed ID: 31579987 [TBL] [Abstract][Full Text] [Related]
10. Vitamin B12 deficiency evaluation and treatment in severe dry eye disease with neuropathic ocular pain. Ozen S; Ozer MA; Akdemir MO Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1173-1177. PubMed ID: 28299439 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a lipid-containing artificial tear compared with a non-lipid containing tear: a randomized clinical trial. Donnenfeld E; Coats J; Barbour K; Ryan R; Joshi NR; Periman LM BMC Ophthalmol; 2024 Oct; 24(1):442. PubMed ID: 39379885 [TBL] [Abstract][Full Text] [Related]
12. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye. McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427 [TBL] [Abstract][Full Text] [Related]
13. The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial. van Setten GB; Baudouin C; Horwath-Winter J; Böhringer D; Stachs O; Toker E; Al-Zaaidi S; Benitez-Del-Castillo JM; Beck R; Al-Sheikh O; Seitz B; Barabino S; Reitsamer HA; Müller-Lierheim WGK J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33147751 [TBL] [Abstract][Full Text] [Related]
14. Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye. Labetoulle M; Chiambaretta F; Shirlaw A; Leaback R; Baudouin C Eye (Lond); 2017 Oct; 31(10):1409-1416. PubMed ID: 28452989 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease. Lee HS; Ji YS; Yoon KC Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of the mineral oil and hyaluronic acid mixture eye drops in murine dry eye. Choi JH; Kim JH; Li Z; Oh HJ; Ahn KY; Yoon KC Korean J Ophthalmol; 2015 Apr; 29(2):131-7. PubMed ID: 25829831 [TBL] [Abstract][Full Text] [Related]
17. The Lubricating Effect of Eye Drops Containing Hyaluronic Acid and Mallow Extract in Patients with Dry Eye Disease-A Pilot Study. Basile AA; Mandelli G; Cendali M; Hufnagel R Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241190 [No Abstract] [Full Text] [Related]
18. A randomized multicenter clinical evaluation of sequential application of 0.3% and 0.15% hyaluronic acid for treatment of dry eye. Jun JH; Bang SP; Park HS; Yoon D; Ahn JY; Kim SJ; Kim HK Jpn J Ophthalmol; 2022 Jan; 66(1):58-67. PubMed ID: 34843023 [TBL] [Abstract][Full Text] [Related]
19. Effect of Single Instillation of Two Hyaluronic Acid-Based Topical Lubricants on Tear Film Thickness in Patients with Dry Eye Syndrome. Szegedi S; Scheschy U; Schmidl D; Aranha Dos Santos V; Stegmann H; Adzhemian N; Fondi K; Bata AM; Werkmeister RM; Couderc C; Schmetterer L; Garhofer G J Ocul Pharmacol Ther; 2018 Nov; 34(9):605-611. PubMed ID: 30325687 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of topical cyclosporine 0.05% and osmoprotective lubricating eye drops in treating dry eye disease and inflammation. Mullick R; Annavajjhala S; Thakur P; Mohapatra A; Shetty R; D'Souza S Indian J Ophthalmol; 2021 Dec; 69(12):3473-3477. PubMed ID: 34826977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]